Construction of recombinant sox2-encoding plasmids that regulate pluripotency of breast cancer stem cells from indonesian patient

A therapy development with recombinant protein is a new and potential innovation to destroy cancer stem cells (CSCs). Various ways of killing CSCs include the provision of polyvalent anti-protein antibodies that code pluripotency. Therefore, it takes a mixture of Oct-4, c-Myc, Sox2, and Klf4 protein...

Full description

Bibliographic Details
Main Authors: Hanifah Rahmi, Tiodinar Theresia, Amarila Malik, Septelia Inawati Wanandi
Format: Article
Language:English
Published: Universitas Ahmad Dahlan 2019-05-01
Series:Pharmaciana
Subjects:
Online Access:http://journal.uad.ac.id/index.php/PHARMACIANA/article/view/11919/pdf_116